Dr. Perkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1250 E Marshall St
Richmond, VA 23298
Education & Training
Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1996 - 1999
Virginia Commonwealth University School of MedicineClass of 1996
Certifications & Licensure
VA State Medical License 1997 - 2024
Publications & Presentations
PubMed
- 25 citationsA phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.Beata Holkova, Jeffrey G. Supko, Matthew M. Ames, Joel M. Reid, Geoffrey I. Shapiro
Clinical Cancer Research. 2013-04-01 - 33 citationsA Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell LymphomaVictor Yazbeck, Danielle Shafer, Edward B. Perkins, Domenico Coppola, Lubomir Sokol
Clinical Lymphoma, Myeloma & Leukemia. 2011-11-18 - 17 citationsPhase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refrac...Beata Holkova, Maciej Kmieciak, E. Brent Perkins, Prithviraj Bose, Rachid Baz
Clinical Cancer Research. 2014-11-15
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
